Atlas Trials

Evaluation of the Effect of Metformin on Metastatic Breast Cancer as Adjuvant Treatment

Clinical trial NCT04143282 · COMPLETED

Trial details

NCT number
NCT04143282
Sponsor
Hager salah el din
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2019-10-20
Primary completion
2020-04-20
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.